Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer

References

• Thompson JF, Shaw HM, Stretch JR, McCarthy WH, Milton GW. The Sydney Melanoma Unit - a multidisciplinary melanoma treatment center. Surg Clin North Am 2003; 83: 431–51.
   Google Scholar
• Troxel DB. Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study. Am J Surg Pathol 2003; 27: 1278–83.
   PubMed Web of Science ®Google Scholar
• McCarthy SW, Scolyer RA. Melanocytic lesions of the face: diagnostic pitfalls. Ann Acad Med Singapore 2004; 33 (Suppl): 1–12.
   Google Scholar
• Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol 1975; 111: 1588–90.
   PubMedGoogle Scholar
• Suster S. Pseudomelanoma. A pathologist's perspective. Int J Dermatol 1986; 25: 506–7.
   PubMed Web of Science ®Google Scholar
• Dymock RB, Menz J. Recurrent melanocytic naevi following partial removal (pseudomelanoma). Australas J Dermatol 1986; 27: 67–9.
   PubMedGoogle Scholar
• Harvell JD, Bastian BC, LeBoit PE. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol 2002; 26: 654–61.
   Google Scholar
• Sanchez JL, Figueroa LD, Rodriguez E. Behavior of melanocytic nevi during pregnancy. Am J Dermatopathol 1984; 6 (Suppl): 89–91.
   Google Scholar
• Lee Hi, Ha SJ, Lee SJ, Kim JW. Melanocytic nevus with pregnancy-related changes in size accompanied by apoptosis of nevus cells: a case report. J Am Acad Dermatol 2000; 42: 936–8.
   PubMed Web of Science ®Google Scholar
• Robson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 2001; 38: 135–40.
   Google Scholar
• Chorny JA, Barr RJ. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002; 24: 309–12.
   PubMed Web of Science ®Google Scholar
• Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635–48.
   PubMed Web of Science ®Google Scholar
• Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19: 3622–34.
   PubMed Web of Science ®Google Scholar
• Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma. Cancer 2003; 97: 1488–98.
   PubMed Web of Science ®Google Scholar
• Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 2004; 11: 426–33.
   PubMed Web of Science ®Google Scholar
• Scolyer RA, Shaw HM, Thompson JF, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol 2003; 27: 1571–6.
   PubMed Web of Science ®Google Scholar
• Crotty KA, Scolyer RA, Li L, et al. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology 2002; 34: 6–12.
   PubMed Web of Science ®Google Scholar
• de Wilt JH, Thompson JF, Uren RF, et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 2004; 239: 544–52.
   PubMed Web of Science ®Google Scholar
• Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 2004; 140: 99–103.
   PubMedGoogle Scholar
• Heenan PJ, Clay CD. Epidermotropic metastatic melanoma simulat-ing multiple primary melanomas. Am J Dermatopathol 1991; 13: 396–402.
   PubMed Web of Science ®Google Scholar
• Thompson JF, Stretch JR, Uren RF, Ka VS, Scolyer RA. Sentinel node biopsy for melanoma: Where have we been and where are we going? Ann Surg Oncol 2004; 11: 147S–51S.
   Google Scholar
• Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000; 7: 469–74.
   PubMed Web of Science ®Google Scholar
• Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 2002; 184: 520–4.
   PubMed Web of Science ®Google Scholar
• Clary BM, Brady MS, Lewis ii, Coit DG. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001; 233: 250–8.
   PubMed Web of Science ®Google Scholar
• Doting MH, Hoekstra Hi, Plukker JT, et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol 2002; 28: 673–8.
   PubMed Web of Science ®Google Scholar
• Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 1999; 6: 442–9.
   PubMed Web of Science ®Google Scholar
• Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16: 2253–60.
   PubMed Web of Science ®Google Scholar
• Harlow SP, Krag DN, Ashikaga T, et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 2001; 11: 45–55.
   PubMed Web of Science ®Google Scholar
• Jansen L, Nieweg OE, Peterse JL, et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000; 87: 484–9.
   PubMed Web of Science ®Google Scholar
• Morton DL, Hoon DS, Cochran Ai, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003; 238: 538–49.
   PubMed Web of Science ®Google Scholar
• Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes — one institution's experience. Melanoma Res 2003; 13: 35–43.
   Google Scholar
• Statius Muller MG, Borgstein PJ, Pijpers R, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 2000; 7: 461–8.
   PubMed Web of Science ®Google Scholar
• Vidal-Sicart S, Pons F, Puig S, et al. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes? Eur J Nucl Med Mol Imaging 2003; 30: 362–6.
   Google Scholar
• Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163: 1765–70.
   PubMed Web of Science ®Google Scholar
• Bastian BC. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 2003; 22: 3081–6.
   PubMed Web of Science ®Google Scholar